Literature DB >> 12524401

Refractory coeliac sprue is a diffuse gastrointestinal disease.

V Verkarre1, V Asnafi, T Lecomte, N Patey Mariaud-de Serre, M Leborgne, E Grosdidier, C Le Bihan, E Macintyre, C Cellier, N Cerf-Bensussan, N Brousse.   

Abstract

BACKGROUND: Refractory coeliac sprue (RCS) with an immunophenotypically aberrant clonal intraepithelial lymphocyte (IEL) population is considered a cryptic form of intestinal T cell lymphoma. AIMS: To investigate the distribution of the abnormal and monoclonal IEL population in the digestive tract of RCS patients. PATIENTS AND METHODS: We compared the frequency of lymphocytic gastritis (LG) and lymphocytic colitis (LC), together with IEL phenotype and T cell clonality, in gastric and colonic samples from 15 adults with RCS (all with aberrant CD3 intracytoplasmic(+) surface(-) CD8(-) clonal IELs on duodenojejunal biopsies), 18 patients with active coeliac disease (ACD), and 10 patients with coeliac disease (CD) on a gluten free diet (GFD-CD) by means of immunohistochemistry and multiplex polymerase chain reaction amplification of the T cell receptor gamma gene (TCR-gamma) rearrangement. Blood samples of nine RCS patients were also tested for clonality.
RESULTS: LG was found in 9/14 (64%), 11/18 (61%), and 3/10 (30%) patients with RCS, ACD, and GFD-CD, respectively, while LC was found in 6/11 (55%), 3/4 (75%), and 2/3 (66%) patients. Contrary to CD, all samples from patients with LG and LC showed an aberrant IEL phenotype. Monoclonal TCR-gamma rearrangements were detected in 8/13 (62%), 8/10 (80%), and 4/9 (44%) of gastric, colonic, and blood samples, respectively, from RCS patients, while in CD patients such rearrangements were only found in 2/25 (8%) gastric samples.
CONCLUSION: The immunophenotypically aberrant monoclonal IEL population present in the small intestine of patients with RCS frequently disseminates to the blood and the entire gastrointestinal epithelium, suggesting that this is a diffuse gastrointestinal disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524401      PMCID: PMC1774980          DOI: 10.1136/gut.52.2.205

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

Review 1.  The histopathology of coeliac disease: time for a standardized report scheme for pathologists.

Authors:  G Oberhuber; G Granditsch; H Vogelsang
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-10       Impact factor: 2.566

2.  Celiac disease and diffuse T-cell lymphoma of the colon.

Authors:  D Pulte; J Murray
Journal:  Gastrointest Endosc       Date:  2001-03       Impact factor: 9.427

3.  From hyperplasia to T cell lymphoma.

Authors:  N Cerf-Bensussan; N Brousse; C Cellier
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

4.  Celiac sprue and refractory sprue.

Authors:  J S Trier; Z M Falchuk; M C Carey; D S Schreiber
Journal:  Gastroenterology       Date:  1978-08       Impact factor: 22.682

5.  Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

Authors:  C Cellier; E Delabesse; C Helmer; N Patey; C Matuchansky; B Jabri; E Macintyre; N Cerf-Bensussan; N Brousse
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

6.  Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue.

Authors:  S Daum; D Weiss; M Hummel; R Ullrich; W Heise; H Stein; E O Riecken; H D Foss
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

7.  Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.

Authors:  J Spencer; N Cerf-Bensussan; A Jarry; N Brousse; D Guy-Grand; A S Krajewski; P G Isaacson
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

8.  Celiac sprue complicated by lymphoma presenting with multiple gastric ulcers.

Authors:  R L Roehrkasse; I M Roberts; A Wald; T S Talamo; H Mendelow
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

9.  Lymphocytic enterocolitis in patients with 'refractory sprue'.

Authors:  R N DuBois; A J Lazenby; J H Yardley; T R Hendrix; T M Bayless; F M Giardiello
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

10.  Intestinal lymphoma associated with malabsorption.

Authors:  P Isaacson; D H Wright
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

View more
  23 in total

1.  Gastrointestinal intraepithelial lymphocytes and T cell lymphomas.

Authors:  I N Farstad; K E A Lundin
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

Review 2.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

Review 3.  CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue.

Authors:  Jaroslav Zivny; Barbara F Banner; Sanjay Agrawal; German Pihan; Graham F Barnard
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

Review 4.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

5.  [Enteropathy type T-cell lymphomas: pathology and pathogenesis].

Authors:  A Zettl; T Rüdiger; H K Müller-Hermelink
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

6.  [20-year old woman with diarrhea of unknown etiology].

Authors:  M Wischmann; A B Buchwald
Journal:  Internist (Berl)       Date:  2006-03       Impact factor: 0.743

7.  Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.

Authors:  K E Smedby; M Akerman; H Hildebrand; B Glimelius; A Ekbom; J Askling
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 8.  Refractory celiac disease: from bench to bedside.

Authors:  Georgia Malamut; Bertrand Meresse; Christophe Cellier; Nadine Cerf-Bensussan
Journal:  Semin Immunopathol       Date:  2012-07-19       Impact factor: 9.623

Review 9.  Pathogenesis of Enteropathy-Associated T Cell Lymphoma.

Authors:  Udit Chander; Rebecca J Leeman-Neill; Govind Bhagat
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

10.  Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.

Authors:  A Al-Toma; W H M Verbeek; M Hadithi; B M E von Blomberg; C J J Mulder
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.